Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Vertex Pharmaceuticals Inc. is a biopharmaceutical company known to use a rational drug design strategy. It dedicates most of its resources to R&D and works to discover, develop, and bring innovative medicines to people with serious diseases. Its medications treat people with cystic fibrosis.

Ticker: VRTX

Humankind Value: $128.8 B

Revenue: $4.9 B

Market Cap: $69.6 B

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Pharmaceutical R&D is one of the most important sources of gains to human life expectancy. Vertex Pharmaceuticals generates positive Humankind Value on balance, primarily due to Healthcare R&D ($109.6 B), Pharmaceuticals ($17.0 B), and Economic Value ($2.1 B). Vertex’s positive value from Healthcare R&D and Pharmaceuticals includes the impact of an estimated 2,626,873.6 additional years lived by people worldwide. However, there is room for improvement with respect to Greenhouse Gases (-$312.1 M) and Air Pollution (-$66.6 M). Values from Healthcare R&D, Pharmaceuticals, Economic Value, Greenhouse Gases, and Air Pollution are attached to this company as a result of its direct business activities.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings